- 2024-08-20 01:51抑制剂CG347B|CG347B|1598426-03-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:51抑制剂CG347B|CG347B|1598426-03-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂CG347B|CG347B|1598426-03-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂CE-245677|CE-245677|717899-97-3|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂CE-245677|CE-245677|717899-97-3|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂cFMS Receptor Inhibitor II|cFMS Receptor Inhibitor II|959860-85-6|Adamas life|≥98%（以实测数值为准）|BR|1m
- 2024-08-20 01:51抑制剂cFMS Receptor Inhibitor II|cFMS Receptor Inhibitor II|959860-85-6|Adamas life|≥98%（以实测数值为准）|BR|25
- 2024-08-20 01:51抑制剂CDK-IN-2 |CDK-IN-2 |1269815-17-9|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂CDN1163|CDN1163|892711-75-0|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂CE-245677|CE-245677|717899-97-3|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:51抑制剂C-DIM12|C-DIM12|178946-89-9|Adamas life|≥97%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂C-DIM12|C-DIM12|178946-89-9|Adamas life|≥97%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂CDK-IN-2 |CDK-IN-2 |1269815-17-9|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:51抑制剂CDK-IN-2 |CDK-IN-2 |1269815-17-9|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂C-DIM12|C-DIM12|178946-89-9|Adamas life|≥97%（以实测数值为准）|BR|100mg
- 2024-08-20 01:51抑制剂CDDO-Im|CDDO-Im|443104-02-7|Adamas life|≥98%（以实测数值为准）|BR|1mg
- 2024-08-20 01:51抑制剂CDDO-Im|CDDO-Im|443104-02-7|Adamas life|≥98%（以实测数值为准）|BR|25mg
- 2024-08-20 01:51抑制剂CDDO-Im|CDDO-Im|443104-02-7|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂CDDO-dhTFEA|CDDO-dhTFEA|1191265-33-4|Adamas life|≥98%（以实测数值为准）|BR|5mg
- 2024-08-20 01:51抑制剂CDDO-dhTFEA|CDDO-dhTFEA|1191265-33-4|Adamas life|≥98%（以实测数值为准）|BR|25mg
